Effects of viral activation of the vessel wall on inflammation and thrombosis

Blood Coagulation and Fibrinolysis

Volumn 9, Issue SUPPL.. 2, 1998, Pages

  Vercellotti, Gregory M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Atherosclerosis; Cytomegalovirus; Endothelium; Herpes virus; Thrombosis; Vascular biology

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10A; CELL ADHESION MOLECULE; PADGEM PROTEIN; PROSTACYCLIN; THROMBOMODULIN; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANTICOAGULATION; BLOOD VESSEL INJURY; CYTOMEGALOVIRUS; ENDOTHELIUM CELL; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IMMUNE ADHERENCE; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; THROMBOSIS; VIRUS INFECTIVITY;

ANEMIA, SICKLE CELL; ARTERIOSCLEROSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; ENDOTHELIUM, VASCULAR; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; INFARCTION; INFLAMMATION; THROMBOSIS;

EID: 0031832063     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Benditt EP, Barret T, McDougall JK. Viruses in the etiology of atherosclerosis. Proc Natl Acad Sci USA 1983; 80: 6386-6389.
2. Melnick JL, Petrie BL, Dreesman GR, Burek J, McCollum CH, DeBakey ME. Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet 1983; ii: 644-647.
3. Zhou YF, Leon MB, Waclwiw MA, Popma JJ, Finkel T, Epstein SE. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 1996; 335: 624-630.
4. MacDonald K, Rector TS, Braunlaw EA, Kubo SH, Olivari MT. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am J Pathol 1989; 64: 359-362.
5. Fabricant CG, Fabricant J, Litrenta MM, Minick CR. Virus-induced atherosclerosis. J Exp Med 1978; 148: 335-340.
6. Peersoons MCJ, Daemen MJAP, Bruning JH, Bruggeman CA. Active cytomegalovirus infection of arterial smooth muscle cells in immunocompromised rats: a clue to herpes virus-associated atherogenesis. Circ Res 1994; 75: 214-220.
7. Cines DB, Lyss AP, Bina M, Corkey R, Kefalides NA, Friedman HM. Fc and C3 receptors induced by herpes simplex virus on cultured human endothelial cells. J Clin Invest 1982; 69: 123-128.
8. Hebbel RP, Visser MR, Goodman JL, Jacob HS, Vercellotti GM. Potentiated adherence of sickle erythrocytes to endothelium infected by virus. J Clin Invest 1987; 80: 1503-1506.
9. Etingin OR, Silverstein RL, Friedman HM, Hajjar DP. Viral activation of the coagulation cascade: molecular interactions at the surface of infected endothelial cells. Cell 1990;61:657-662.
10. MacGregor RR, Friedman HM, Macarak EJ, Kefalides NA. Virus infection of endothelial cells increases granulocyte adherence. J Clin Invest 1980;65:1469-1477.
11. Visser MR, Jacob HS, Goodman JL, McCarthy JB, Furcht LT, Vercellotti GM. Granulocyte-mediated injury to herpes simplex-infected human endothelium. Lab Invest 1989; 60: 296-304.
12. Etingin OR, Silverstein RL, Haggar DP. Identification of a monocyte receptor on herpes virus-infected endothelial cells. Proc Natl Acad Sci USA 1991; 88: 7200-7203.
13. Sedmak DD, Knight DA, Vook NC, Waldman WJ. Divergent patterns of ELAM-1, ICAM-1, and VCAM-1 expression on cytomegalovirus-infected endothelial cells. Transplantation 1994; 58: 1379-1385.
14. Span AH, van Dam-Mieras MC, Mullers W, Endert J, Muller AD, Bruggeman CA. The effect of virus infection on the adherence of leukocytes or platelets to endothelial cells. Clin Invest 1991;21: 331-338.
15. Hajjar DP. Viral pathogenesis of atherosclerosis. Am J Pathol 1991; 139:1195-1211.
16. Visser MR, Tracy PB, Vercellotti GM, Goodman JL, White JG, Jacob HS. Enhanced thrombin generation and platelet binding on herpes simplex virus-infected endothelium. Proc Natl Acad Sci USA 1988; 85: 8227-8230.
17. Altieri DC, Etingin OR, Fair DS, Brunck TK, Geltosky HE, Hajjar DP, Edgington TS. Structurally homologous ligand binding of integrin Mac-1 and viral glycoprotein C receptors. Science 1991; 254: 1200-1202.
18. Pryzdial ELG, Wright JF. Prothrombinase assembly on an enveloped virus: evidence that the cytomegalovirus surface contains procoagulant phospholipid. Blood 1994; 84: 3749-3757.
19. Key NS, Bach RR, Vercellotti GM, Moldow CF. Herpes simplex virus type I does not require productive infection to induce tissue factor in human umbilical vein endothelial cells. Lab Invest 1993; 68: 645-651.
20. Key NS, Vercellotti GM, Winkelmann JC, Moldow CF, Goodman JL, Esmon NL, et al. Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression. Proc Natl Acad Sci USA 1990; 87: 7095-7099.
21. Kaner RJ, Iozzo RV, Ziaie Z, Kefalides NA. Inhibition of proteoglycan synthesis in human endothelial cells after infection with HSV type-1, in vitro. Am J Respir Cell Mol Biol 1990; 2: 423-431.
22. Etingin OR, Silverstein RL, Haggar DP. von Willebrand factor mediates platelet adhesion to virally infected endothelium. Proc Natl Acad Sci USA 1993; 90: 5153-5156.
23. Vercellotti GM. Potential role of viruses in thrombosis and atherosclerosis. Trends Cardiovasc Med 1995; 5: 128-133.
24. Percivalle E, Revello MG, Vago L, Gerna G. Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infections with organ involvement. J Clin Invest 1993; 92 (suppl 2): 663-670.